Amgen And Merck Expand Upon Collaboration For Head And Neck Cancer Drug Combo
May 29, 2015 at 21:47 PM EDT
Amgen and Merck agree to expand upon a previous partnership in order to develop a combination drug for patients with head and neck cancer
